Mylan

Ahead of merger with Pfizer's generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio
Ahead of merger with Pfizer's generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio
Endpoints
Mylan
Europe
generics
Aspen Pharmacare
M&A
thrombosis
Pfizer
Flag link:
FDA scolds Mylan for 'repeated' manufacturing problems
FDA scolds Mylan for 'repeated' manufacturing problems
BioPharma Dive
FDA
generics
Mylan
drug manufacturing
India
Flag link:
Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought
Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought
Center for Biosimilars
Biocon
Mylan
Semglee
generics
insulin
diabetes
biosimilars
Flag link:
Mylan yanks four lots of heart health, hemophilia injectables over packaging mix-up
Mylan yanks four lots of heart health, hemophilia injectables over packaging mix-up
Fierce Pharma
Mylan
product recalls
packaging
Flag link:
Mylan launches first generic to Tecfidera in multiple sclerosis
Mylan launches first generic to Tecfidera in multiple sclerosis
Seeking Alpha
Mylan
generics
Tecfidera
Biogen
MS
multiple sclerosis
Flag link:
Mylan takes $1M gift to Sesame Street to help families cope with the pandemic
Mylan takes $1M gift to Sesame Street to help families cope with the pandemic
Fierce Pharma
Mylan
philanthropy
pandemic
COVID-19
Flag link:
Biogen's last-ditch pitch for an injunction to protect Tecfidera is denied, paving way for Mylan generic
Biogen's last-ditch pitch for an injunction to protect Tecfidera is denied, paving way for Mylan generic
Endpoints
Biogen
Tecfidera
Mylan
generics
Flag link:
Mylan and Pfizer roll out tricolor branding for their giant generics combo, Viatris
Mylan and Pfizer roll out tricolor branding for their giant generics combo, Viatris
Fierce Pharma
Mylan
Pfizer
Upjohn
M&A
generics
Viatris
branding
Flag link:
Mylan, seeking to market Victoza generic, convinces panel to start up patent review
Mylan, seeking to market Victoza generic, convinces panel to start up patent review
Fierce Pharma
Mylan
patents
generics
Novo Nordisk
Victoza
diabetes
Flag link:
Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch
Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch
Fierce Pharma
Biogen
Tecfidera
Mylan
patents
generics
MS
multiple sclerosis
Flag link:
Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan
Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan
Fierce Pharma
Biogen
Mylan
Tecfidera
patents
MS
multiple sclerosis
Flag link:
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
Motley Fool
FDA
Mylan
Biocon
Semglee
Sanofi
insulin
Lantus
diabetes
Flag link:
What's Behind Mylan's Mixed Q1 Results
What's Behind Mylan's Mixed Q1 Results
Motley Fool
Mylan
Pfizer
Upjohn
M&A
Viatris
earnings
Flag link:
Mylan's Robert Coury returns to exec chairman role amid pandemic, delayed merger
Mylan's Robert Coury returns to exec chairman role amid pandemic, delayed merger
Beckers Hospital Review
Mylan
Robert Coury
Upjohn
generics
M&A
COVID-19
pandemic
Flag link:
Mylan prepares hydroxychloroquine giveaways after production ramp-up
Mylan prepares hydroxychloroquine giveaways after production ramp-up
Fierce Pharma
Mylan
hydroxychloroquine
COVID-19
drug manufacturing
Flag link:
Biocon insulin operation gets FDA nod, paving way for approval of Lantus knockoff
Biocon insulin operation gets FDA nod, paving way for approval of Lantus knockoff
Fierce Pharma
Biocon
insulin
diabetes
Lantus
Mylan
drug manufacturing
Flag link:
Mylan, Pfizer offer undisclosed concessions as part of EU merger review
Mylan, Pfizer offer undisclosed concessions as part of EU merger review
Fierce Pharma
Mylan
Pfizer
Upjohn
Europe
M&A
Flag link:
FDA warns of premature EpiPen auto-injector activations
FDA warns of premature EpiPen auto-injector activations
Fierce Biotech
FDA
EpiPens
Mylan
Flag link:
Pfizer, Mylan say COVID-19 delays will postpone their Viatris merger
Pfizer, Mylan say COVID-19 delays will postpone their Viatris merger
Fierce Pharma
COVID-19
Pfizer
Mylan
Viatris
M&A
Flag link:
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
Motley Fool
COVID-19
Gilead Sciences
Mylan
Bayer
chloroquine
hydroxychloroquine
Fujifilm
Avigan
Kevzara
Actemra
Regeneron
Sanofi
Roche
Flag link:

Pages